Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Go back to Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
(NASDAQ: SILO) Delayed: 6.12 +0.31 (5.34%)
Previous Close $5.81    52 Week High
Open $5.81    52 Week Low
Day High $6.50    P/E N/A 
Day Low $5.68    EPS
Volume 99,083